Ticagrelor Versus Clopidogrel and Eptifibatide Bolus in Patients With Stable or Unstable Angina Undergoing Coronary Intervention: A Randomized Pharmacodynamic Study

Trial Profile

Ticagrelor Versus Clopidogrel and Eptifibatide Bolus in Patients With Stable or Unstable Angina Undergoing Coronary Intervention: A Randomized Pharmacodynamic Study

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Bivalirudin (Primary) ; Clopidogrel (Primary) ; Eptifibatide (Primary) ; Heparin (Primary) ; Ticagrelor (Primary)
  • Indications Angina pectoris
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top